NCT07180186Completed
Microbiota and Probiotic Therapy in Ulcerative Colitis Patients
Evaluation of Microbiota and Probiotic Therapy in Ulcerative Colitis Patients
Source: ClinicalTrials.gov · Last updated 18 Sept 2025
Brief summary (registry, in English)
This study aimed to evaluate the role of microbiota and probiotics in Egyptian patients with ulcerative colitis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 70 (actual)
- First submitted
- 11 Sept 2025
- Start date
- 1 Jan 2022
- Primary completion date
- 1 May 2024
- Lead sponsor
- Tanta University
- Diseases
- Ulcerative colitis
- NCT number
- NCT07180186
What you commit to
- Study type: Observational
- Participants enrolled: 70
- From 1 Jan 2022 to the primary completion date, 1 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously taking other probiotics.
- Use of steroids within the last 4 weeks before study entry.
- Use of antibiotics within the last 2 weeks before study entry
Other illness
- Cardiac, hepatic, or renal disease.
- History of major colonic surgery.
- Patients with any malignancy.
Other
- Active ulcerative colitis.
- Pregnancy.
Who the study is looking for
- Patients more than 18 years.
- Patients with ulcerative colitis in remission as assessed by the clinical activity index (CAI) ≤ 4, endoscopic index (EI) ≤ 4, and no signs of acute inflammation on histological examination.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tanta university Coordinator of this site? Confirm its status | Tanta | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.